ADELIS, THE WORLD LEADER IN ULTRA SENSITIVE FLUORESCENCE DETECTION

ADELIS continues to offer its customers LED induced Fluorescence (LEDIF) and Laser induced Fluorescence (LIF) detection technologies under the brand name PICOMETRICS.

ADELIS is currently developing a new range of products based on an innovative, patented concentration, separation and purification technique (μLAS) invented by the French National Research Agency (CNRS). The μLAS platform, named Biabooster « Add-on », is an enabling technology, which paves the way to profile from low (100 bp) to high (> 200 kbp) molecular weight DNA for a large range of market applications. In particular, the technology is the unique technology able to profile circulating cell-free DNA in blood samples.

ADELIS recently offers cfDNA analysis services as service delivery or in partnership extending its large analytical methods portfolio for its customers. Its sister company ID-Solutions offers a complete workflow for oncology diagnostic on circulating DNA from liquid biopsy and tumor DNA from solid biopsy.

WHAT IS NEW?

OFFRE D’EMPLOI

Technicien(ne) de Laboratoire CDD de 6 mois à compter du 01/03/2021 Nous recherchons un(e) Technicien(ne) de Laboratoire pour consolider notre applica...

MSB 2020, April 5-8, Saint-Malo, France

Join us at the 36th International Symposium on Microscale Separations and Bioanalysis and attend our presentation on “Concentration and separation of...

Reportage France 3 – 08/11/2016 

Toulouse : une méthode rapide pour déceler un cancer

La startup Picometrics, à Labège, a mis au point une méthode de séquençage de l’ADN très rapide pour détecter les tumeurs cancéreuses

Video France 3 : une méthode rapide pour déceler un cancer

 

 

 

Picometrics Technologies est soutenu par la Région dans ses projets de recherche collaborative avec le CNRS-LAAS et l’INSERM-CRCT.